• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Zodorm
    / Unipharm

    Active Ingredient
    Zolpidem (tartrate) 5 mg, 10 mg

    Status in Israel

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft


    20 X 10 mg

    partial basket chart 4398 26106


    20 X 5 mg

    partial basket chart

    Related information


    One tablet before bedtime.
    See prescribing information for full details.


    Short term treatment of insomnia.


    Hypersensitivity, severe sleep apnea syndrome, acute repiratory insufficiency, psychiatric disturbances, severe hepatic insufficiency.

    Special Precautions

    Caution in patients showing symptoms of depression, minimum as possible amount of the drug should be supplied to the patient. Termination of treatment will be accompanied by withdrawal symptoms. The duration of hypnotic treatment should be as short as possible but should not exceed one month including tapering off period. Rebound insomnia may occur on withdrawal of hypnotic treatment. This may be accompanied by other reactions including mood changes, anxiety and restlessness. It is important that the patient be aware of the possibility of rebound phenomena. Sedation, amnesia and impaired muscular function may adversely affect the ability to drive or to use machines while taking hypnotics. Avoid use during pregnancy and lactation.

    Side Effects

    During hypnotic use: derealization, depersonalisation, hyperacusis, numbness, tingling of the extemities, hypersensitivity to light, noise and physical contact, hallucinations and epileptic seizures. Paradoxical reactions like restlessness, agitation, irritability, rages, hallucinations, may occur when using hypnotics.


    Trima Israel Pharmaceutical Products Maabarot Ltd. Israel